ArticleFrontiers in oncology2020

One Single Site Clinical Study: To Evaluate the Safety and Efficacy of Immunotherapy With Autologous Dendritic Cells, Cytokine-Induced Killer Cells in Primary Hepatocellular Carcinoma Patients.

Kaiyue Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.